SCHEMBL5697886

SCHEMBL5697886

CC(OC(=O)NCc1ccccc1-c1ccccc1OC(=O)NCCc1ccccn1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 7/20 0.63
KCNA3 P22001 2/20 0.63
TAS1R3 Q7RTX0 2/20 0.47
TAS1R1 Q7RTX1 2/20 0.47
KCNK3 O14649 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
KCNH2 Q12809 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
HTT P42858 1/20 0.37
ENPP2 Q13822 1/20 0.37
FAAH O00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5697897 1.00 KCNA5 (0.63) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL5697855 1.00 KCNA5 (0.63) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL5697890 0.91 KCNA5 (0.76) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL727201 0.91 KCNA5 (0.76) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL2210715 0.88 KCNA5 (0.82) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL2207907 0.88 KCNA5 (0.82) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL2207911 0.88 KCNA5 (0.82) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL12434009 0.79 KCNA5 (0.79) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL5697901 0.78 KCNA5 (0.56) KCNA5KCNA3TAS1R3TAS1R1KCNK3
SCHEMBL2212471 0.78 KCNA5 (1.00) KCNA5KCNA3TAS1R3TAS1R1KCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222163-B1 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS SANOFI AVENTIS DEUTSCHLAND (DE) 2006-07-12 EP disclosed
EP-1222163-A1 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS Aventis Pharma Deutschland GmbH (DE) 2002-07-17 EP disclosed
WO-2001025189-A1 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-04-12 WO disclosed